ELIZABETH A LANO to Angiogenesis Inhibitors
This is a "connection" page, showing publications ELIZABETH A LANO has written about Angiogenesis Inhibitors.
Connection Strength
0.012
-
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91.
Score: 0.012